Peripheral Artery Disease

Peripheral artery disease (PAD) involves atherosclerosis mainly in the extremities, especially in the legs and feet that lead to ischemia. Untreated, PAD can progress to critical limb ischemia (CLI), also called chronic limb-threatening ischemia (CLTI), which will lead to foot or leg amputation. The mortality rate for these CLI amputees is 70% within three years. There is currently an epidemic of PAD and CLI in the U.S. The majority of patients are defined by health disparities concentrated in the Black, Latino, Native American populations in both rural and low-income urban areas. A large number of PAD patients have other comorbities, with diabetes being one a primary issue.

Drug-coated balloons make little impact on PAD outcomes
Researchers tracked data from more than 3,000 patients, calling for more clinical trials of antiproliferative agents other than paclitaxel.
Abbott’s dissolving stent picks up a key approval
It's another big victory for Abbott's bioresorbable stent for BTK PAD.
New liquid embolic agent for hypervascular tumors gains FDA’s premarket approval
Instylla's Embrace Hydrogel Embolic System minimizes bleeding risks during the embolization of hypervascular tumors in the peripheral arteries.
Medtronic expands peripheral portfolio with new distribution deal
The company has finalized an exclusive distribution deal with Future Medical Design to sell its stainless steel peripheral guidewires in the United States.
New guidelines help interventional cardiologists manage chronic venous disease
"These recommendations will help ensure that patient care remains both consistent and personalized," SCAI President Srihari S. Naidu, MD, explained.

PAD patients more likely to die from COVID-19

The mortality rate for COVID-19 patients was nearly twice as high if they had a history of peripheral artery disease, researchers found.

Many PAD patients are missing out on vital risk assessments

The findings, based on Medicare data, were presented at VIVA21 in Las Vegas.

First patient treated with CSI’s new peripheral support catheter

A vascular surgeon in Nashville performed the procedure, praising the device's "balance of support and flexibility."

Rivaroxaban limits adverse limb and cardiovascular events in surgically treated PAD patients

Rivaroxaban was associated with more bleeding than a placebo, researchers observed, but the overall incidence of such events was still low.

Bill would bolster coverage of interventional radiology services to help Americans avoid amputations

Lawmakers recently introduced the Amputation Reduction and Compassion Act in the House, with bipartisan backing and support from the Society of Interventional Radiology.

M&A mergers and acquisitions business deal

Endologix acquires medical device company focused on peripheral artery disease

PQ Bypass, the company Endologix acquired, has gained significant attention for its Detour platform, an investigational treatment for percutaneous femoral-popliteal bypass.

Championing Alternative PAD Access in the Office-based Lab

Peripheral Artery Disease

Drug-coated balloons make little impact on PAD outcomes

Abbott’s dissolving stent picks up a key approval

New liquid embolic agent for hypervascular tumors gains FDA’s premarket approval

Medtronic expands peripheral portfolio with new distribution deal

New guidelines help interventional cardiologists manage chronic venous disease